Abstract：OBJECTIVE: This research intends to amplify the entire coding region sequences of SLC25A13 mRNA which encodes citrin, and to investigate sequence features of the transcripts for this gene in cultured human amniocytes. This study will provide laboratory evidence for prenatal diagnosis of neonatal intrahepatic cholestasis caused by citrin deficiency (NICCD) at mRNA level. METHODS: One amniocyte sample was collected from a pregnant woman who underwent prenatal diagnosis of citrin deficiency and whose fetus has proven a carrier of 851del4 mutation by genomic DNA analysis. Another amniocyte sample, as a control, was from a fetus without family history of citrin deficiency. Total RNA was extracted from cultured amniocytes, cDNA was synthesized, and then nested-PCR was performed to amplify the entire coding region sequences of SLC25A13. The PCR products were cloned and analyzed by sequencing. RESULTS: The entire coding region of SLC25A13 gene was successful amplified from two cultured human amniocytes. The splice variant of SLC25A13, SLCA (normal mRNA), was identified in the two samples. SLCB (CAG insertion between exon 9-10) was identified in the control. SLCC (exon 5-11 skipping), but not transcriptional product from the allele with 851del4 mutation, was identified in the 851del4 mutation carrier. CONCLUSIONS: This study demonstrated that the entire coding region of SLC25A13 cDNA can be successfully amplified from two cultured human amniocytes, and revealed exon 5-11 skipping as a novel SLC25A13 transcript. Normal mRNA predominated in the transcripts in normal control and 851del4 mutation carrier, suggesting that the two fetuses were not at risk for NICCD. These SLC25A13 transcription features provided laboratory evidence for prenatal diagnosis of NICCD.
ZHANG Zhan-Hui,ZHAO Xin-Jing,SONG Yuan-Zong et al. Cloning and sequence analysis of SLC25A13 transcripts in human amniocytes[J]. CJCP, 2012, 14(3): 221-225.
［1］Kobayashi K, Sinasac DS, Iijima M, Boright AP, Begum L, Lee JR, et al. The gene mutated in adult-onset type II citrullinaemia encodes a putative mitochondrial carrier protein［J］. Nat Genet, 1999, 22(2): 159-163.
［2］Saheki T, Kobayashi K. Mitochondrial aspartate glutamate carrier (citrin) deficiency as the cause of adult-onset type II citrullinemia (CTLN2) and idiopathic neonatal hepatitis (NICCD)［J］. J Hum Genet, 2002, 47(7): 333-341.
［4］Lu YB, Kobayashi K, Ushikai M, Tabata A, Iijima M, Li MX, et al. Frequency and distribution in East Asia of 12 mutations identified in the SLC25A13 gene of Japanese patients with citrin deficiency［J］. J Hum Genet, 2005, 50(7): 338-346.
［5］Kobayshi K, Ushikai M, Song YZ, Gao HZ, Sheng JS, Tabata A, et al. Overview of citrin deficiency: SLC25A13 mutations and the frequency［J］. J Appl Clin Pediatr, 2008, 23(20): 1553-1557.
［6］Song YZ, Li BX, Hao H, Xin RL, Zhang T, Zhang CH, et al. Selective screening for inborn errors of metabolism and secondary methylmalonic aciduria in pregnancy at high risk district of neural tube defects: a human metabolome study by GC-MS in China［J］. Clin Biochem, 2008, 41(7-8): 616-620.
［10］Song YZ, Deng M, Chen FP, Wen F, Guo L, Cao SL, et al. Genotypic and phenotypic features of citrin deficiency: five-year experience in a Chinese pediatric center［J］. Int J Mol Med, 2011, 28(1): 33-40.
［11］Song YZ, Li BX, Chen FP, Liu SR, Sheng JS, Ushikai M, et al. Neonatal intrahepatic cholestasis caused by citrin deficiency: clinical and laboratory investigation of 13 subjects in mainland of China［J］. Dig Liver Dis, 2009, 41(9): 683-689.
［12］Tabata A, Sheng JS, Ushikai M, Song YZ, Gao HZ, Lu YB, et al. Identification of 13 novel mutations including a retrotransposal insertion in SLC25A13 gene and frequency of 30 mutations found in patients with citrin deficiency［J］. J Hum Genet, 2008, 53(6): 534-545.
［15］Zhao XJ, Tang XM, Zha QB, Shi SS, Song YZ, Xiao XM. Prenatal diagnosis of citrin deficiency in a Chinese family with a fatal proband［J］. Tohoku J Exp Med, 2011, 225(4): 273-276.
［17］Shigeta T, Kasahara M, Kimura T, Fukuda A, Sasaki K, Arai K, et al. Liver transplantation for an infant with neonatal intrahepatic cholestasis caused by citrin deficiency using heterozygote living donor［J］. Pediatr Transplant, 2010, 14(7): E86-E88.
［18］Ohura T, Kobayashi K, Tazawa Y, Abukawa D, Sakamoto O, Tsuchiya S, et al. Clinical pictures of 75 patients with neonatal intrahepatic cholestasis caused by citrin deficiency (NICCD)［J］. J Inherit Metab Dis, 2007, 30(2): 139-144.
［19］Tokuhara D, Iijima M, Tamamori A, Ohura T, Takaya J, Maisawa S, et al. Novel diagnostic approach to citrin deficiency: analysis of citrin protein in lymphocytes［J］. Mol Genet Metab, 2007, 90(1): 30-36.
［22］Wang ET, Sandberg R, Luo S, Khrebtukova I, Zhang L, Mayr C, et al. Alternative isoform regulation in human tissue transcriptomes［J］. Nature, 2008, 456(7221): 470-476.
［23］Weiss C, Zeng Y, Huang J, Sobocka MB, Rushbrook JI. Bovine NAD+-dependent isocitrate dehydrogenase: alternative splicing and tissue-dependent expression of subunit 1［J］. Biochemistry, 2000, 39(7): 1807-1816.
［24］Hosler R, Kerick M, Mah N, Hultschig C, Richter G, Bretz F, et al. Alterations of pre-mRNA splicing in human inflammatory bowel disease［J］. Eur J Cell Biol, 2011, 90(6-7): 603-611.
［25］Hansson O, Zhou Y, Renstrom E, Osmark P. Molecular function of TCF7L2: Consequences of TCF7L2 splicing for molecular function and risk for type 2 diabetes［J］. Curr Diab Rep, 2010, 10(6): 444-451.
［26］Maquat LE. Nonsense-mediated mRNA decay: splicing, translation and mRNP dynamics［J］. Nat Rev Mol Cell Biol, 2004, 5(2): 89-99.
［27］Frischmeyer PA, Dietz HC. Nonsense-mediated mRNA decay in health and disease［J］. Hum Mol Genet, 1999, 8(10): 1893-1900.
